Stepwise Medical Treatment of Cushing's Disease: a prospective, open label, multi-center trial with SOM230 mono- and combination therapy with dopamine agonists and ketoconazole for treatment of Cushing's disease

Trial Profile

Stepwise Medical Treatment of Cushing's Disease: a prospective, open label, multi-center trial with SOM230 mono- and combination therapy with dopamine agonists and ketoconazole for treatment of Cushing's disease

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 14 May 2009

At a glance

  • Drugs Cabergoline; Ketoconazole; Pasireotide
  • Indications Pituitary ACTH hypersecretion
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top